Bausch + Lomb Corporation (BLCO)

Market Cap	6.15B
Revenue (ttm)	3.77B
Net Income (ttm)	58.00M
Shares Out	350.00M
EPS (ttm)	0.17
PE Ratio	102.41
Forward PE	23.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,865
Open	17.15
Previous Close	17.41
Day's Range	17.45 - 17.75
52-Week Range	12.20 - 20.20
Beta	n/a
Analysts	Buy
Price Target	19.89 (+13.4%)
Earnings Date	Feb 22, 2023

About BLCO

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 12,800
• Stock Exchange: NYSE
• Ticker Symbol: BLCO

Analyst Forecast

According to 18 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $19.89, which is an increase of 13.40% from the latest price.

Price Target

$19.89

(13.40% upside)

Analyst Consensus: Buy